By clicking “Accept All Cookies”, you agree to the storing of cookies on your device to enhance site navigation, analyze site usage, and assist in our marketing efforts. View our Privacy Policy for more information.

Driving Global Health Innovation with AI-Powered Data Solutions

We make biomedical data AI-ready, unlocking actionable insights with scalable solutions.

01/04

Powering Precision Medicine with Multimodal AI & Data Innovation

Our AI-powered Platform- Polly integrates clinical, omics, and imaging data, accelerating R&D and driving impactful outcomes.

02/04

Establishing Best Practices in Data Security and Quality

Ensuring trusted data with robust security frameworks, stringent compliance standards, and validated quality checks for biomedical research and development organizations.

03/04

Trusted by Industry Leaders

Biopharma innovators rely on our AI-powered platform- Polly to streamline data workflows and optimize research outcomes.

04/04

First place winners: NCI-CRDC (Cancer Research Data Commons) AI Data Readiness Challenge!

Recognized as 'Most Innovative Company in Biotech, 2024' by Fast Company!

Voices of Impact

Designing patient-specific immunotherapies is challenging due to variability in tumor antigens and immune responses. Elucidata's solutions helped us deepen our understanding of neoantigen-reactive T cells, advancing our T-cell-based anti-tumor therapies. Collaborating with Elucidata enabled crucial insights within six months, offering a clear direction on how to best develop these complex therapeutics.

Rubén Alvarez Rodriguez
Head of Research, cTRL Therapeutics

Elucidata has been a key partner at NGJ, supporting every step from discovery to pipeline development, testing, and quality system establishment. Together, we’ve explored novel insights in uterine science, developed multi-omics data analysis approaches, and created methods for studying challenging sample types. Their team is knowledgeable, inquisitive, and dedicated to advancing scientific understanding with innovative tools.

Stephen Gire
CSO, NextGen Jane

Elucidata has consistently provided the expertise needed, whether it’s software development, R computing, open-source software integration like Kraken and degnorm, IT infrastructure, RNA-seq alignment, AWS cloud integration, or Linux server management. Even when faced with out-of-scope challenges, Elucidata has delivered by bringing in the right experts.

Xitong Li
CTO, NextGen Jane

We were looking for public data on a tight deadline to make decisions on our back up targets for solid tumors. Elucidata was able to understand our relevance criteria, identify, and deliver high-quality harmonized data ahead of schedule. We are really happy with their deliveries and this partnership.

Ming 'Tommy' Tang
Director of Computational Biology, Immunitas Therapeutics

Data analysis is the biggest bottleneck for metabolomics research. Elucidata has worked directly with us to streamline our analysis pipeline, accelerating the pace of our research.

Dr. Russel Jones
Lead Investigator, Van Andel Institute

We really were pleasantly surprised because this tool [El-MAVEN] is really useful in fast analysis of tracer data. It allows us to really look at a broad set of targets so you are not limited anymore for data analysis. A data analyst of mine stepped up to me and said, "I can do now in 3 hours what used to take 4 days.

Bart Ghesquière
Head of Metabolomics Core Facility, VIB

Extremely impressed by Polly and its power to digest and integrate large datasets. The unique partnership that we have allows us to work hand-in-hand with software engineers and scientists to rapidly develop novel hypotheses that we can test in the lab.

Dr. Kate Yen
Founder & CEO, Auron Therapeutics

My overall experience has been good, they provide an actively developed and well documented python package to access the provided data and metadata and is pretty straightforward to use and integrate in pipelines. They have a really quick and effective support when facing any issues and they provide answers, solutions and fixes, Elucidata is attentive to its user’s needs and uses that to improve the user experience with new features and higher quality of the data/metadata provided.

Thomas Rosnet
Data Engineer/Operator, Owkin

Collaboration with Elucidata is seamless. They are flexible, efficient, and on-time to meet our internal deadlines. They foster an environment of open communication that has resulted in a great process of data delivery of publicly available data and they are proactive in resolving issues.

Jorge Arellano
Data Steward, Owkin

It’s been a pleasure collaborating with Elucidata to structure our EMR reports. Their team was diligent in understanding the data extraction module, responsive to updates, and offered valuable advice on data organization, ensuring our system will remain useful as our dataset grows.

Claire Toth
Research Associate, EMR Data Curation

Data processing and scientific reporting of metabolomics data are crucial but also tedious. Polly’s range of applications helped our team in accelerating these processes significantly and effectively.

Dewakar Sangaraju
Senior Scientist, Genentech

Trusted by the World's Leading Biopharma R&D Teams

Technology

Polly: The Only AI-Ready Data Platform

By combining pillars of people, processes, and technology, Polly streamlines complex workflows, increases productivity, and delivers reusable, findable, access controlled AI-ready Data Products, powering end-to-end decision support.

Streamline multimodal data integration, accelerate drug discovery and development, and derive actionable insights with our scalable, AI-powered platform

Integrated Data Management

  • Seamlessly unify EHRs, omics, imaging, and clinical trial data in a single platform.

  • LLM-powered metadata extraction and enrichment for high-quality insights.

Scalable Infrastructure

  • Supports 26+ data types and 30+ bioinformatics pipelines.

  • SOC2, HIPAA, and GDPR-compliant for secure data handling.

AI-Driven Insights

  • AI-assisted cohort builders and dashboards for faster decision-making.

  • Predictive modeling and visualizations to identify high-risk patients and recommend treatment plans.

Customer Stories

AI Chatbot Optimizes Data Retrieval for Speed & Human-Level Accuracy

See how a leading pharma company harnessed Elucidata’s LLM-powered chatbot with optimized RAG to streamline data retrieval and query execution. With 2X better performance and 5X faster insights, the chatbot provides easy access to multi-modal data without coding required.

Learn More

Modernizing Gene Therapy R&D with Automated Pipelines

Discover how a US-based biopharma company optimized its AAV-genome sequencing pipeline with Elucidata. By automating virion analysis and cassette quality assessment, they achieved 0.01% plasmid purity accuracy while cutting pipeline development costs by 4X.

Learn More

Accelerating Translational Research with Curated Datasets

Learn how a South San Francisco-based translational research company advanced target discovery and lowered preclinical toxicity risks with Elucidata’s data curation expertise. By building a high-quality dataset and using harmonized single-cell and bulk RNA-seq data, they boosted predictive efficiency in Treg-cell biology.

Learn More

Refining Single-Cell Data Processing to Accelerate Cancer Diagnostics

Discover how a US-based cancer diagnostics company sought to improve its RNA-seq workflow for Acute Myeloid Leukemia (AML) research with Elucidata. By streamlining data ingestion, processing, and analysis, they eliminated inefficiencies, ensured seamless scalability, and saved $1.34M in compute costs.

Learn More

Quantifiable Results for Smarter Research

4X

Cheaper Data Product Generation

Cost-efficient data products built with optimized pipelines.

2X

Faster Model Development

Accelerates deployment and time to market for therapies.

$2M+

Annual Cost Savings

Achieved through reduced operational costs and scalable solutions.

Find the Right Use Case for Your Data

Start Your Journey with
AI-Driven Biomedical Data Solutions